Skip to main content
TG Therapeutics, Inc. (TGTX)
NASDAQ: TGTX · Real-Time Price · USD
32.53
-0.97 (-2.90%)
Dec 27, 2024, 4:00 PM EST - Market closed

TG Therapeutics Revenue

TG Therapeutics had revenue of $83.88M in the quarter ending September 30, 2024, a decrease of -49.41%. This brings the company's revenue in the last twelve months to $264.79M, up 39.53% year-over-year. In the year 2023, TG Therapeutics had annual revenue of $233.66M with 8,290.02% growth.

Revenue (ttm)
$264.79M
Revenue Growth
+39.53%
P/S Ratio
17.79
Revenue / Employee
$1,002,992
Employees
264
Market Cap
4.67B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2023233.66M230.88M8,290.02%
Dec 31, 20222.79M-3.90M-58.36%
Dec 31, 20216.69M6.54M4,300.66%
Dec 31, 2020152.00K--
Dec 31, 2019152.00K--
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro
Dec 31, 2014 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
RadNet 1.77B
Integer Holdings 1.71B
Alkermes 1.51B
Telix Pharmaceuticals 430.80M
Krystal Biotech 241.52M
BridgeBio Pharma 217.77M
PROCEPT BioRobotics 199.84M
Arcellx 155.82M
Revenue Rankings

TGTX News

More News